You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.
The hybridization-based test may provide better detection of emerging COVID-19 variants of concern, due to a higher tolerance for probe mismatches than in PCR.
Scipher will use the proceeds to further commercialize PrismRA, a molecular test intended to guide treatment decisions for patients with rheumatoid arthritis.
The company was founded in 2017 to commercialize a small, battery-powered, disposable RT-PCR system called the Nuclein Hand-Held PCR Test.
NeoGenomics will offer Trapelo's clinical decision support system to providers, payors, and labs to aid precision oncology across all healthcare settings.
The firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences Lending Fund.
With support from Color and through a network of testing laboratories, Thermo Fisher will offer integrated COVID-19 testing to school districts nationwide.
The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring.
The company said the test detects four SARS-CoV-2 variants and two biologically significant mutations, all of which are now prevalent globally.
The firm's CEO said that its MDx system is available for research use and going through CE-IVD marking ahead of its full commercial launch.
CellMax also completed a Series C financing round to speed up development of itsFirstSight liquid biopsy test to detect colorectal cancer and precancer polyps.
Todos said that after implementing its automation equipment, Majl will be able to run approximately 1,500 PCR-based COVID-19 tests per day.
The firm said it will begin running its urine-based test immediately in its clinical laboratory in Munich and make it available throughout Europe.
Artificial will provide access to its aLab Suite software, which integrates with the Thermo Scientific Momentum Workflow software and robotics hardware.
A prescription-only version of the test was first authorized last year for the detection of three SARS-CoV-2 genes in a range of samples.
The firm also recently validated its instrument-agnostic technology's ability to detect up to 20 targets per qPCR well using high-definition PCR.
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.
The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018.
The firm expects an expanding market for at-home self-testing and is differentiating its products in part through their ease of use.
The firm's revenue decrease was largely driven by a decline in testing volumes due to the COVID-19 pandemic, it said.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.